A Study to Assess the Safety and Effectiveness of Tacrolimus Cream in the Treatment of Psoriasis

A study to assess the safety and effectiveness of tacrolimus cream in the treatment of psoriasis

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Psoriasis Skin Diseases Skin Diseases, Papulosquamous Skin and Connective Tissue Diseases

Age range

12 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 3

Primary location

Winnipeg, Manitoba, Canada

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Clinical diagnosis of plaque psoriasis

Exclusion criteria

Skin disorder other than plaque psoriasis in the areas to be treated.
Disease on only elbows, knees, and scalp

Treatment and study plan

Tacrolimus

Drug

Sponsors and collaborators

Lead sponsor

Astellas Pharma Inc

Industry

Collaborators

Astellas Pharma US, Inc.

Registry information

Important dates

Study completion: 2006
First posted: Feb 20, 2006
Registry last updated: Dec 24, 2007

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed